A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Clinical trial NCT04123470 · COMPLETED
Trial details
- NCT number
- NCT04123470
- Sponsor
- Lokon Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-28
- Primary completion
- 2023-07-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.